These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4901100)

  • 1. [Experimental study on chemotherapy of urinary tract infection. 4. Effect of urinary pH on the effects of penicillin derivatives against Escherichi coli].
    Igari J; Kunisada Y; Koike K
    Jpn J Antibiot; 1969 Aug; 22(4):319-22. PubMed ID: 4901100
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
    So W; Crandon JL; Nicolau DP
    J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New penicillins in the treatment of urinary tract infection.
    Geedes AM; McGhie D; Hutchison JG; Mahood CB
    Kidney Int Suppl; 1975 Aug; 4():S134-7. PubMed ID: 811918
    [No Abstract]   [Full Text] [Related]  

  • 4. Infections of the urinary tract. II. Management.
    Wing AJ
    Br Med J; 1970 Oct; 4(5726):35-8. PubMed ID: 4919120
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibility of influencing the antibacterial effect of erythromycin by changes of urinary pH in experimental E. coli infections of the urinary tract].
    Prát V; Loew H; Konícková L; Hatala M
    Cas Lek Cesk; 1971; 110(21):481-5. PubMed ID: 4931773
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aminocyclohexyl penicillin (Cyclacillin)].
    Ueda Y; Matsumoto F; Nakamura N; Saito A; Noda K
    Jpn J Antibiot; 1970 Feb; 23(1):48-52. PubMed ID: 4915210
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of Hetacillin in gynecology].
    Seika K; Yamaji K; Ahara M
    J Antibiot B; 1966 Oct; 19(5):358-9. PubMed ID: 5339562
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic study on chemotherapy of urinary tract infection. II. Effect of urine pH on antibacterial activity of chemotherapeutics on Escherichia coli].
    Igari J; Kondo H; Kudo M; Kano M
    Jpn J Antibiot; 1968 Jun; 21(3):118-23. PubMed ID: 4301952
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basic study on chemotherapy of urinary tract infection. 3. Effect of urine pH on antibacterial activity of macrolides, lincomycin and clinimycin on Escherichia coli].
    Igari J; Kano M
    Jpn J Antibiot; 1968 Dec; 21(6):354-7. PubMed ID: 4887887
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carbenicillin in experimental E. coli and Pseudomonas urinary tract infections].
    Prát V; Konícková L; Ritzerfeld W
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):220-2. PubMed ID: 4917427
    [No Abstract]   [Full Text] [Related]  

  • 11. The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1974 Jun; 55(3):245-50. PubMed ID: 4607731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of urinary infections with amoxycillin].
    Peromet M; Schoutens E; Yourassowsky E
    Chemotherapy; 1973; 18():Suppl:52-6. PubMed ID: 4576489
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997.
    Dyer IE; Sankary TM; Dawson JA
    West J Med; 1998 Nov; 169(5):265-8. PubMed ID: 9830353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine inhibitory titers against resistant Escherichia coli isolates after oral amoxicillin-sulbactam.
    Casellas JM; Visser M; MacDougall N; Tomé G; Cohen HS; Soutric J; Arenoso H;
    Medicina (B Aires); 2003; 63(3):211-4. PubMed ID: 12876904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of hetacillin].
    Nakagawa K; Kabe J; Watanabe K; Yokozawa M
    Jpn J Antibiot; 1969 Oct; 22(5):361-3. PubMed ID: 4903719
    [No Abstract]   [Full Text] [Related]  

  • 16. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
    Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
    BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
    Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
    J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection.
    Tasbakan MI; Pullukcu H; Sipahi OR; Yamazhan T; Ulusoy S
    Int J Antimicrob Agents; 2012 Dec; 40(6):554-6. PubMed ID: 23063743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red urine in a returning traveller.
    Chan SY; Evans D
    Int J STD AIDS; 2005 Nov; 16(11):770-1. PubMed ID: 16303080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.